High-throughput screening identifies three inhibitor classes of the telomere resolvase from the lyme disease spirochete

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 10, 2009, Pages 4441-4449

  Lefas, Georgia ^a   Chaconas, George ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISPIROCHETAL AGENT; DNA; RESOLVASE; REST INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; DRUG DESIGN; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; GENE LIBRARY; HIGH THROUGHPUT SCREENING; IC 50; LYME DISEASE; MOLECULE; NONHUMAN; PRIORITY JOURNAL; SPIROCHETE; SURVIVAL; TELOMERE; TRANSESTERIFICATION;

ANIMALS; BACTERIAL PROTEINS; BORRELIA BURGDORFERI; ENZYME INHIBITORS; HUMANS; LYME DISEASE; RECOMBINASES;

EID: 70349317380     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00529-09     Document Type: Article

References (39)

1. Bankhead, T., and G. Chaconas. 2004. Mixing active site components: a recipe for the unique enzymatic activity of a telomere resolvase. Proc. Natl. Acad. Sci. USA 101:13768-13773.
2. Bankhead, T., K. Kobryn, and G. Chaconas. 2006. Unexpected twist: harnessing the energy in positive supercoils to control telomere resolution. Mol. Microbiol. 62:895-905.
3. Barbour, A. G., and C. F. Garon. 1987. Linear plasmids of the bacterium Borrelia burgdorferi have covalently closed ends. Science 237:409-411.
4. Beaurepaire, C., and G. Chaconas. 2005. Mapping of essential replication functions of the linear plasmid lp17 of B. burgdorferi by targeted deletion walking. Mol. Microbiol. 57:132-142.
5. Bono, J. L., A. F. Elias, J. J. Kupko III, B. Stevenson, K. Tilly, and P. Rosa. 2000. Efficient targeted mutagenesis in Borrelia burgdorferi. J. Bacteriol. 182:2445-2452.
6. Burgin, A. B. 2001. Synthesis and use of DNA containing a 5′-bridging phosphorothioate as a suicide substrate for type I DNA topoisomerases. Methods Mol. Biol. 95:119-128.
7. Byram, R., P. E. Stewart, and P. Rosa. 2004. The essential nature of the ubiquitous 26-kilobase circular replicon of Borrelia burgdorferi. J. Bacteriol. 186:3561-3569.
8. Casjens, S., M. Murphy, M. DeLange, L. Sampson, R. van Vugt, and W. M. Huang. 1997. Telomeres of the linear chromosomes of Lyme disease spirochaetes: nucleotide sequence and possible exchange with linear plasmid telomeres. Mol. Microbiol. 26:581-596.
9. Casjens, S., N. Palmer, R. Van Vugt, W. H. Huang, B. Stevenson, P. Rosa, R. Lathigra, G. Sutton, J. Peterson, R. J. Dodson, D. Haft, E. Hickey, M. Gwinn, O. White, and C. M. Fraser. 2000. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 35:490-516. (Pubitemid 30085269)
10. Chaconas, G. 2005. Hairpin telomere and genome plasticity in Borrelia: all mixed up in the end. Mol. Microbiol. 58:625-635.
11. Chaconas, G., P. E. Stewart, K. Tilly, J. L. Bono, and P. Rosa. 2001. Telomere resolution in the Lyme disease spirochete. EMBO J. 20:3229-3237. (Pubitemid 32612010)
12. Deneke, J., A. B. Burgin, S. L. Wilson, and G. Chaconas. 2004. Catalytic residues of the telomere resolvase ResT: a pattern similar to, but distinct from tyrosine recombinases and type IB topoisomerases. J. Biol. Chem. 279:53699-53706.
13. Dolan, M. C., N. S. Zeidner, E. Gabitzsch, G. Dietrich, J. N. Borchert, R. M. Poche, and J. Piesman. 2008. A doxycycline hyclate rodent bait formulation for prophylaxis and treatment of tick-transmitted Borrelia burgdorferi. Am. J. Trop. Med. Hyg. 78:803-805.
14. Dragovich, P. S., T. J. Prins, R. Zhou, S. A. Fuhrman, A. K. Patick, D. A. Matthews, C. E. Ford, J. W. Meador III, R. A. Ferre, and S. T. Worland. 1999. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. J. Med. Chem. 42:1203-1212.
15. Fraser, C. M., S. Casjens, W. M. Huang, G. G. Sutton, R. Clayton, R. Lathigra, O. White, K. A. Ketchum, R. Dodson, E. K. Hickey, M. Gwinn, B. Dougherty, J. F. Tomb, R. D. Fleischmann, D. Richardson, J. Peterson, A. R. Kerlavage, J. Quackenbush, S. Salzberg, M. Hanson, R. van Vugt, N. Palmer, M. D. Adams, J. Gocayne, J. Weidman, T. Utterback, L. Watthey, L. McDonald, P. Artiach, C. Bowman, S. Garland, C. Fujii, M. D. Cotton, K. Horst, K. Roberts, B. Hatch, H. O. Smith, and J. C. Venter. 1997. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580-586.
16. Hinnebusch, J., and A. G. Barbour. 1991. Linear plasmids of Borrelia burgdorferi have a telomeric structure and sequence similar to those of a eukaryotic virus. J. Bacteriol. 173:7233-7239.
17. Hunfeld, K. P., and V. Brade. 2006. Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know. Wien Klin. Wochenschr. 118:659-668.
18. Kobryn, K., A. B. Burgin, and G. Chaconas. 2005. Uncoupling the chemical steps of telomere resolution by ResT. J. Biol. Chem. 280:26788-26795.
19. Kobryn, K., and G. Chaconas. 2005. Fusion of hairpin telomeres by the B. burgdorferi telomere resolvase ResT: implications for shaping a genome in flux. Mol. Cell 17:783-791.
20. Kobryn, K., and G. Chaconas. 2002. ResT, a telomere resolvase encoded by the Lyme disease spirochete. Mol. Cell 9:195-201. (Pubitemid 34127783)
21. Matthews, D. A., P. S. Dragovich, S. E. Webber, S. A. Fuhrman, A. K. Patick, L. S. Zalman, T. F. Hendrickson, R. A. Love, T. J. Prins, J. T. Marakovits, R. Zhou, J. Tikhe, C. E. Ford, J. W. Meador, R. A. Ferre, E. L. Brown, S. L. Binford, M. A. Brothers, D. M. DeLisle, and S. T. Worland. 1999. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc. Natl. Acad. Sci. USA 96:11000-11007.
22. McGovern, S. L., E. Caselli, N. Grigorieff, and B. K. Shoichet. 2002. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J. Med. Chem. 45:1712-1722.
23. Morgan, A. R., J. S. Lee, D. E. Pulleyblank, N. L. Murray, and D. H. Evans. 1979. Ethidium fluorescence assays. Part 1. Physicochemical studies. Nucleic Acids Res. 7:547-569.
24. Ogden, N. H., M. Bigras-Poulin, C. J. O'Callaghan, I. K. Barker, L. R. Lindsay, A. Maarouf, K. E. Smoyer-Tomic, D. Waltner-Toews, and D. Charron. 2005. A dynamic population model to investigate effects of climate on geographic range and seasonality of the tick Ixodes scapularis. Int. J. Parasitol. 35:375-389.
25. Ogden, N. H., A. Maarouf, I. K. Barker, M. Bigras-Poulin, L. R. Lindsay, M. G. Morshed, C. J. O'Callaghan, F. Ramay, D. Waltner-Toews, and D. F. Charron. 2006. Climate change and the potential for range expansion of the Lyme disease vector Ixodes scapularis in Canada. Int. J. Parasitol. 36:63-70.
26. Payne, D. J., M. N. Gwynn, D. J. Holmes, and D. L. Pompliano. 2007. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6:29-40.
27. Picardeau, M., J. R. Lobry, and B. J. Hinnebusch. 1999. Physical mapping of an origin of bidirectional replication at the centre of the Borrelia burgdorferi linear chromosome. Mol. Microbiol. 32:437-445.
28. Piesman, J. 2006. Strategies for reducing the risk of Lyme borreliosis in North America. Int. J. Med. Microbiol. 296(Suppl. 40):17-22.
29. Purser, J. E., and S. J. Norris. 2000. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc. Natl. Acad. Sci. USA 97:13865-13870.
30. Spielman, A. 1994. The emergence of Lyme disease and human babesiosis in a changing environment. Ann. N. Y. Acad. Sci. 740:146-156.
31. Stanek, G., and F. Strle. 2008. Lyme disease: European perspective. Infect. Dis. Clin. N. Am. 22:327-339.
32. Steere, A. C., J. Coburn, and L. Glickstein. 2004. The emergence of Lyme disease. J. Clin. Investig. 113:1093-1101.
33. Steere, A. C., V. K. Sikand, F. Meurice, D. L. Parenti, E. Fikrig, R. T. Schoen, J. Nowakowski, C. H. Schmid, S. Laukamp, C. Buscarino, and D. S. Krause for the Lyme Disease Vaccine Study Group. 1998. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N. Engl. J. Med. 339:209-215.
34. Tourand, Y., T. Bankhead, S. L. Wilson, A. D. Putteet-Driver, A. G. Barbour, R. Byram, P. A. Rosa, and G. Chaconas. 2006. Differential telomere processing by Borrelia telomere resolvases in vitro but not in vivo. J. Bacteriol. 188:7378-7386.
35. Tourand, Y., J. Deneke, T. J. Moriarty, and G. Chaconas. 2009. Characterization and in vitro reaction properties of 19 unique hairpin telomeres from the linear plasmids of the Lyme disease spirochete. J. Biol. Chem. 284:7264-7272.
36. Tourand, Y., K. Kobryn, and G. Chaconas. 2003. Sequence-specific recognition but position-dependent cleavage of two distinct telomeres by the Borrelia burgdorferi telomere resolvase, ResT. Mol. Microbiol. 48:901-911.
37. Tourand, Y., L. Lee, and G. Chaconas. 2007. Telomere resolution by Borrelia burgdorferi ResT through the collaborative efforts of tethered DNA binding domains. Mol. Microbiol. 64:580-590.
38. Tsao, J. I., J. T. Wootton, J. Bunikis, M. G. Luna, D. Fish, and A. G. Barbour. 2004. An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle. Proc. Natl. Acad. Sci. USA 101:18159-18164.
39. Zhang, J. H., T. D. Chung, and K. R. Oldenburg. 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4:67-73.